alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › staging

staging

5 studies tagged staging, dated 2017-01-01 to 2025-03-17. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Biofluid-based staging of Alzheimer's disease 2025-03-17
  2. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup 2024-06-27
  3. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups 2024-01-06

Studies

5 studies carry this tag.

Date range

2017 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Journal of Alzheimer's disease : JAD 2
  • Acta neuropathologica 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Biofluid-based staging of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Acta neuropathologica 2025-03-17 Biomarkers

    Recently, conceptual systems for the in vivo staging of Alzheimer's disease (AD) using fluid biomarkers have been suggested.

  2. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-06-27 Biomarkers

    The National Institute on Aging and the Alzheimer's Association convened three separate work groups in 2011 and single work groups in 2012 and 2018 to create recommendations for the diagnosis and characterization of Alzheimer's disease (AD).

  3. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-01-06 Biomarkers

    This study demonstrated the utility of a blood-based, multi-pathway biomarker assay for early screening and staging of AD, providing insights for patient stratification and precision medicine.

  4. Medial Temporal Lobe Atrophy in Predementia Alzheimer's Disease: A Longitudinal Multi-Site Study Comparing Staging and A/T/N in a Clinical Research Cohort

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of Alzheimer's disease : JAD 2023-01-01 Biomarkers

    We found MTL neurodegeneration largely consistent with existing models, suggesting that harmonized MRI volumetry may be used under conditions that are common in clinical multi-center cohorts.

  5. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of Alzheimer's disease : JAD 2017-01-01 Biomarkers

    Oligomeric forms of amyloid-β (Aβ), tau, and TDP-43 play important roles in Alzheimer's disease (AD), and therefore are promising biomarkers.

All topic tags with their study counts